Inventor · disambiguated record
Oliver Lenz
Also filed as: LENZ OLIVER
11 granted patents·12 pending applications·78 citations·filing 2005–2021
87Inventor score
Files withJANSSEN PHARMACEUTICALS INC4SYMRISE AG4TIBOTEC PHARM LTD4JANSSEN SCIENCES IRELAND UC2JANSSEN SCIENCES IRELAND UNLIMITED CO2
Top patents by PatentIndex Score
23 records- 0196US8030318B2Fused bicyclic inhibitors of HCVTIBOTEC PHARM LTD·Filed 2006·Granted Oct 4, 2011·31 cites·3 claims
- 0293US8022077B2Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereofTIBOTEC PHARM LTD·Filed 2006·Granted Sep 20, 2011·31 cites·22 claims
- 0383US7977342B2HCV inhibiting bi-cyclic pyrimidinesTIBOTEC VIRCO VIROLOGY BVBA·Filed 2007·Granted Jul 12, 2011·9 cites·9 claims
- 0480US9290502B2Pteridines useful as HCV inhibitors and methods for the preparation thereofTIBOTEC PHARM LTD·Filed 2013·Granted Mar 22, 2016·3 cites·12 claims
- 0576US10589241B2Method for storing cooling agentsSYMRISE AG·Filed 2016·Granted Mar 17, 2020·2 cites·13 claims
- 0671US10973801B2Capsid assembly modulator dosing regimenJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Apr 13, 2021·1 cites·18 claims
- 0768US10328405B2Process for the production of solid cooling agentsSYMRISE AG·Filed 2015·Granted Jun 25, 2019·1 cites·7 claims
- 0860US9708328B2Pteridines useful as HCV inhibitors and methods for the preparation thereofJANSSEN SCIENCES IRELAND UC·Filed 2016·Granted Jul 18, 2017·0 cites·7 claims
- 0959US2017275288A1Pteridines useful as hcv inhibitors and methods for the preparation thereofJANSSEN SCIENCES IRELAND UC·Filed 2017·Application pending·0 cites
- 1059US2009156595A1Pteridines useful as HCV inhibitors and methods for the preparation thereofTIBOTEC PHARM LTD·Filed 2006·Application pending·0 cites
- 1157US9987277B2Carboxamide 4-[(4-pyridyl)amino] pryimidines for the treatment of hepatitis CRABOISSON PIERRE JEAN MARIE BERNARD·Filed 2007·Granted Jun 5, 2018·0 cites·27 claims
- 1256US2024217904A1Method for preparing cedrene diolSYMRISE AG·Filed 2021·Application pending·0 cites
- 1355US2011171174A1Synergistic Combinations of a Macrocyclic Inhibitor of HCV and a NucleosideORTHO MCNEIL JANSSEN PHARM·Filed 2009·Application pending·0 cites
- 1454US2021285000A1Combination therapy for treating hepatitis b virus infectionJANSSEN PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1554US2021395745A1Rnai agents for hepatitis b virus infectionARROWHEAD PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1651US2021260025A1Capsid assembly modulator dosing regimenJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2021·Application pending·0 cites
- 1750US2021403908A1Compositions and methods for treatment of hepatitis d virus infectionJANSSEN PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1849US9951075B2Pteridines useful as HCV inhibitors and methods for the preparation thereofJanssen Sciencies Ireland UC·Filed 2016·Granted Apr 24, 2018·0 cites·12 claims
- 1945US2020330499A1Combination therapy for treating hepatitis b virus infectionJANSSEN PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2045US2020332297A1Combination therapy for treating hepatitis b virus infectionJANSSEN PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2143US12403076B2Compositions comprising odorless 1,2-pentanediolSYMRISE AG·Filed 2018·Granted Sep 2, 2025·0 cites·9 claims
- 2237US2013028865A1Combination of a Macrocyclic Inhibitor of HCV, A Non-Nucleoside and a NucleosideMEDIVIR AB·Filed 2011·Application pending·0 cites
- 2337US2009011000A1Inhibitors of InfectionHINZ ANDREAS·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Oliver Lenz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →